Trials

  • October 28, 2026

    UMC Settles Suit Over Ex-Panasonic Chip Patents Before Trial

    Taiwanese chipmaker United Microelectronics Corp. notified a Texas federal court Tuesday that it has agreed to settle a suit alleging that it infringed seven semiconductor patents originally issued to Japan's Panasonic Corp., days before a trial was set to begin.

  • October 28, 2026

    Versata Wants Ford To Pay Interest Atop Restored $82M Award

    Versata Software Inc. wants a Michigan federal court to tack on at least $37.7 million to a reinstated $82.3 million contract award against Ford Motor Co. and said the court should finalize that win while both sides prepare for a new trade secret damages trial.

  • October 28, 2026

    Sanofi Settles Insulin Pen Antitrust Suit, Avoiding Trial

    Sanofi-Aventis US and a group of drug wholesalers have told a Massachusetts federal judge they have reached a settlement to resolve long-running antitrust litigation alleging that the drugmaker improperly sought to thwart competition for its single-use insulin injector pen.

  • October 28, 2026

    Judge Hellerstein, Gruff Moderator Of Major Cases, Dies At 92

    Judge Alvin K. Hellerstein, a former litigator and sometimes impatient Manhattan federal jurist who presided over decades of high-profile cases that often came under close appellate scrutiny, died Wednesday at the age of 92.

  • October 27, 2026

    At 4th Circ., DOJ Admits But Downplays Goldstein Trial Errors

    The U.S. Department of Justice late Tuesday acknowledged that it confused key statutory terms related to jury instructions at famed appellate advocate Tom Goldstein's criminal trial, while also insisting "the government's mistake here was understandable" and shouldn't upend a jury's guilty verdict.

  • October 27, 2026

    3 Federal Circuit Clashes To Watch In November

    A high-stakes case that will determine whether the U.S. government should face patent infringement claims over Moderna's COVID-19 vaccines and Labcorp's appeal of a nine-figure patent verdict against it are among the arguments the Federal Circuit will hear in November.

  • October 27, 2026

    Mallet Wins Injunction On Release Of Baking Product Secrets

    Baking product company Mallet & Co. was granted a permanent injunction Tuesday to stop a rival from accessing or disclosing its trade secrets after a federal judge ordered the rival to pay $11.4 million in legal bills for sharing copied goods in publicly accessible court documents.

  • October 27, 2026

    Soldier Can't Slip Charges Over Maduro Raid Polymarket Bet

    A U.S. Army soldier must face charges that he profited from insider knowledge of the raid that captured deposed Venezuelan President Nicolás Maduro after a Manhattan federal judge ruled that whether his prediction market trades ran afoul of commodities laws is a question for trial.

  • October 27, 2026

    Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More

    Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other legal news from the past week.

  • October 27, 2026

    RE Execs, Brother Get 30 Years For 'Monstrous' Sex Assaults

    A Manhattan federal judge hit two wealthy former real estate executives and their brother with 30 years each in prison Tuesday, after a jury convicted the three Florida men of a 13-year campaign of trafficking, drugging and raping women and minors.

  • October 27, 2026

    Daily Mail, Publishers Fight Google's 'Multi-Year Delay'

    Gannett, the Daily Mail and a certified class of website publishers urged a New York federal judge Monday not to let Google pause a scheduled advertising placement technology trial, arguing in twin briefs that the U.S. Department of Justice's antitrust win is strong and Google's appeal won't disrupt the multidistrict litigation.

  • October 27, 2026

    ​​​​​​​Drugmakers Seek To Bar 'Big Pharma' Label In Price-Fix Trial

    A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of pharmaceuticals and healthcare" in next year's trial.

  • October 26, 2026

    Google Says DOJ Overreaching With Proposed Antitrust Fixes

    Google has told a D.C. federal court that the U.S. Department of Justice and state enforcers are trying to force it into unreasonable antitrust measures that go beyond what the court imagined when it handed down its remedies order in the monopolization suit.

  • October 26, 2026

    Meta Docs Reveal Plan To Discredit Teen-Harm Critic Haidt

    Meta internally set a goal to "get the academic community to disavow" and "turn against" professor Jonathan Haidt, who has linked social media use to mental health decline, as it in-house rebuffed internal efforts to study social media's impact on teen health, according to recently unredacted documents filed publicly Friday.

  • October 26, 2026

    Trump Media Investor Says Firm Reaped $18M On Inside Info

    A Trump Media & Technology Group Corp. shareholder told jurors in Florida federal court on Monday that the $18 million a venture capital firm made when Trump Media went public should be returned because it was the result of insider trading.

  • October 26, 2026

    Salsa Producer Had Rights To 3 Albums, Jury Finds

    A federal jury in Miami came back with a mixed verdict Friday in a dispute between a Venezuelan salsa composer and his former business partner and producer, finding the producer had a valid license for three of the six albums at issue and owned one of two trademarks.

  • October 26, 2026

    Pa. Court Affirms $9.5M Verdict Over Botched Vasectomy

    A Pennsylvania appellate panel Monday affirmed a $9.5 million verdict in a suit accusing a doctor of botching a man's vasectomy that caused the loss of a testicle, saying the verdict was supported by sufficient evidence.

  • October 26, 2026

    Comcast, Viamedia Settle Cable Ad Antitrust Case Before Trial

    Comcast Corp. and Viamedia Inc. have reached a settlement in their decadelong antitrust battle over the cable advertising market just days before a jury trial was set to begin in Illinois federal court over allegations the cable giant is monopolizing local advertising markets.

  • October 26, 2026

    In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

    A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment unimpeded, after previously allowing the enforcers to challenge that revocation in the first case set for trial.

  • October 26, 2026

    Mich. Panel Backs $9.7M Negligence Verdict Against Hospital

    A Michigan appeals court declined to upend a hospital's share of a $9.7 million jury verdict for administrative negligence in its care for a woman who died while receiving emergency treatment for complications following an abdominoplasty, or "tummy tuck" procedure.

  • October 26, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week approved a $250 million settlement of litigation over Microsoft Corp.'s acquisition of Activision Blizzard Inc., while Albertsons Cos. Inc. accused Kroger Co. of rejecting changes that could have saved their $24.6 billion merger, and the Delaware Supreme Court ordered Verisk Analytics Inc. to keep pursuing a $2.35 billion acquisition.

  • October 26, 2026

    Radiology Co. Strikes Deal In ESOP Fight Ahead Of Trial

    Radiology company Envision and its trustee have settled a class action claiming they brokered an inflated $163.7 million stock sale to the business' employee stock ownership plan, staving off a bench trial that was days away from kicking off, according to a Colorado federal court filing.

  • October 23, 2026

    Teva, Eli Lilly Spar Over Possible New Drug Patent Trial

    Eli Lilly and Teva on Friday sparred over whether a new trial should be held in Massachusetts federal court over the validity of patents related to Teva's migraine drug Ajovy after the Federal Circuit reversed the Boston court's judgment that favored Eli Lilly.

  • October 23, 2026

    'Millennial VC' Loses New Trial Bid Over Alleged Atty Failure

    A California federal judge on Thursday denied convicted self-described "millennial" venture capitalist Michael Rothenberg's latest new trial bid, rejecting his argument that his prior counsel's failure to consult a forensic accountant undermined his defense nearly three years after a jury found him guilty of money laundering and fraud.

  • October 23, 2026

    Colorado Excavation Co. Sues Attys Over Invalid $3.7M Lien

    Three Colorado law firms and their attorneys engaged in professional negligence by failing to timely file a valid lien statement for a former client seeking to obtain more than $3.7 million from a customer for its excavation services, a Colorado excavation company alleged in state court.

Expert Analysis

  • 3 Strategies To Reduce AI Sycophancy In Legal Work

    Author Photo

    The tendency of generative artificial intelligence models to tell users what they want to hear can reinforce attorneys’ confirmation bias when testing the strength of arguments, and it can’t simply be prompted away — but a few practices can help mitigate it, says Michael Ott at Ice Miller.

  • Open Issues After 2nd Circ.'s Airport Phone Search Ruling

    Author Photo

    While the Second Circuit’s recent U.S. v. Alisigwe decision confirms border agents' broad authority to conduct routine manual cellphone searches at ports of entry, significant questions remain about more wide-ranging forensic searches at the border, say attorneys at Baker Botts.

  • 2nd Circ. EFAA Ruling Shifts Employer Litigation Strategy

    Author Photo

    In Diaz-Roa v. Hermes Law, the Second Circuit recently held that, under the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act, employers can't carve out nonharassment claims and send them to arbitration, which has implications for discovery, litigation costs and resolution strategy in EFAA-covered disputes, say attorneys at Krevolin Horst.

  • Bribery Verdict Offers Guide To Post-Pause FCPA Priorities

    Author Photo

    A former Goldman Sachs investment banker's recent Foreign Corrupt Practices Act conviction offers insights into how the U.S. Department of Justice is applying its FCPA guidelines following the Trump administration's 2025 pause on enforcement, and illustrates the importance of a company’s escalation procedures and follow-through, say attorneys at Debevoise.

  • AG Watch: Minnesota Takes Action To Secure Child Safety

    Author Photo

    Minnesota Attorney General Keith Ellison has built one of the most aggressive and structurally coherent child protection enforcement programs in the country, targeting consumer-facing sectors that his office has concluded prey on minors, such as tobacco and nicotine, social media platforms, and artificial intelligence, say attorneys at Crowell & Moring.

  • Southern Glazer's Deal Tests FTC's Robinson-Patman Push

    Author Photo

    A California federal court's recent decision in Federal Trade Commission v. Southern Glazer's secures a rare Robinson-Patman Act pricing limitations agreement, but conditions attached to the decision indicate that practitioners may only see a handful of new private RPA cases a year, says Steven Cernak at Bona Law.

  • How DC Circ. Ruling Permits Playacting Bribery Defense

    Author Photo

    The D.C. Circuit’s recent U.S. v. Burke decision appears to create a circuit split on whether prosecutors must prove public officials’ intent in bribery cases, and opens a gap between what appears to be corrupt conduct and what the law can reach, says Liz Aloi at MoFo.

  • Series

    Being In The Peace Corps Made Me A Better Lawyer

    Author Photo

    When I served in the Peace Corps, the people of the West African village where I was stationed helped me acclimate to my new surroundings and enabled me to develop problem-solving, teamwork and empathy skills that have bolstered my legal practice far beyond the ability to offer technical advice, says Brian Bewley at McGuireWoods.

  • What $5.7B Apple Verdict Reveals About Patent Risk

    Author Photo

    A California federal jury's recent $5.7 billion damages verdict against Apple exemplifies the enormous financial exposure that can occur when patent-infringing features are incorporated into many units, though the outcome is ultimately dependent on the strength of the underlying infringement, validity and damages theories, says Michael Dorfman at Barclay Damon.

  • 5 Ways Trial Attys Can Build Mental Health Counseling Skills

    Author Photo

    Studies demonstrate that many attorneys are not equipped to respond adequately to trauma exposure, but trial lawyers can build several key skills drawn from mental health counseling into their interactions with clients and colleagues, from cognitive reappraisal to boundary setting, says Alexandra Echsner-Rasmussen at Aylstock Witkin.

  • AGs' Paramount Settlement Reflects States' Growing Influence

    Author Photo

    The recent California federal court approval of the California v. Paramount Skydance settlement illustrates how state attorneys general are gaining new independence and influence, and companies must account for state enforcement when assessing merger risks ahead of a deal's closing, say attorneys at Norton Rose.

  • How Rule 45 Update May Change Remote Trial Subpoenas

    Author Photo

    The Committee on Rules of Practice and Procedure's recently recommended update to Rule 45 of the Federal Rules of Civil Procedure would expand trial courts’ subpoena power for remote testimony, but it would not alter the standard for authorizing remote testimony and may prompt unresolved questions for foreign witnesses, say attorneys at WilmerHale.

  • Reel Justice: 'The Odyssey' And Making Tough Trial Choices

    Author Photo

    In “The Odyssey,” Odysseus succeeds because he abandons the search for a perfect answer, highlighting for litigators why successful advocacy is about making thoughtful choices that circumvent cognitive biases and mental shortcuts, says Veronica Finkelstein at Widener-Delaware Law.

  • Rebuttal

    North Carolina's Funding Ban Is An Outlier, Not A Model

    Author Photo

    A recent Law360 guest article argues that North Carolina's litigation funding ban should be adopted by other states, but that analysis overstates what North Carolina did and misjudges how the law will travel, says Dai Wai Chin Feman at the International Legal Finance Association.

  • What's At Stake As Justices Rethink Sentencing Commentary

    Author Photo

    Tuesday’s oral arguments before the U.S. Supreme Court in Beaird v. U.S. highlighted the tension between preserving sentencing consistency and limiting the authority of sentencing guidelines commentary, and a decision favoring the latter could significantly reduce sentencing exposure for white collar defendants, say attorneys at Baker Donelson.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here